Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA

ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pradeep Kumar, Glenn C. Capodagli, Divya Awasthi, Riju Shrestha, Karishma Maharaja, Paridhi Sukheja, Shao-Gang Li, Daigo Inoyama, Matthew Zimmerman, Hsin Pin Ho Liang, Jansy Sarathy, Marizel Mina, George Rasic, Riccardo Russo, Alexander L. Perryman, Todd Richmann, Aditi Gupta, Eric Singleton, Sheetal Verma, Seema Husain, Patricia Soteropoulos, Zhe Wang, Roxanne Morris, Gene Porter, Gautam Agnihotri, Padmini Salgame, Sean Ekins, Kyu Y. Rhee, Nancy Connell, Véronique Dartois, Matthew B. Neiditch, Joel S. Freundlich, David Alland
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a3287
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d6c465583e4410c8afdd48c4a9a3287
record_format dspace
spelling oai:doaj.org-article:8d6c465583e4410c8afdd48c4a9a32872021-11-15T15:52:19ZSynergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA10.1128/mBio.02101-172150-7511https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a32872018-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02101-17https://doaj.org/toc/2150-7511ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interacting DG167 molecules occupying nonidentical sites in the substrate-binding channel of KasA. The binding affinities of KasA to DG167 and its analog, 5g, which binds only once in the substrate-binding channel, were determined, along with the KasA-5g X-ray crystal structure. DG167 strongly augmented the in vitro activity of isoniazid (INH), leading to synergistic lethality, and also synergized in an acute mouse model of M. tuberculosis infection. Synergistic lethality correlated with a unique transcriptional signature, including upregulation of oxidoreductases and downregulation of molecular chaperones. The lead structure-activity relationships (SAR), pharmacokinetic profile, and detailed interactions with the KasA protein that we describe may be applied to evolve a next-generation therapeutic strategy for tuberculosis (TB). IMPORTANCE Cell wall biosynthesis inhibitors have proven highly effective for treating tuberculosis (TB). We discovered and validated members of the indazole sulfonamide class of small molecules as inhibitors of Mycobacterium tuberculosis KasA—a key component for biosynthesis of the mycolic acid layer of the bacterium’s cell wall and the same pathway as that inhibited by the first-line antitubercular drug isoniazid (INH). One lead compound, DG167, demonstrated synergistic lethality in combination with INH and a transcriptional pattern consistent with bactericidality and loss of persisters. Our results also detail a novel dual-binding mechanism for this compound as well as substantial structure-activity relationships (SAR) that may help in lead optimization activities. Together, these results suggest that KasA inhibition, specifically, that shown by the DG167 series, may be developed into a potent therapy that can synergize with existing antituberculars.Pradeep KumarGlenn C. CapodagliDivya AwasthiRiju ShresthaKarishma MaharajaParidhi SukhejaShao-Gang LiDaigo InoyamaMatthew ZimmermanHsin Pin Ho LiangJansy SarathyMarizel MinaGeorge RasicRiccardo RussoAlexander L. PerrymanTodd RichmannAditi GuptaEric SingletonSheetal VermaSeema HusainPatricia SoteropoulosZhe WangRoxanne MorrisGene PorterGautam AgnihotriPadmini SalgameSean EkinsKyu Y. RheeNancy ConnellVéronique DartoisMatthew B. NeiditchJoel S. FreundlichDavid AllandAmerican Society for MicrobiologyarticleantitubercularDG167KasAMycobacterium tuberculosismycolic acid biosynthesisdrug developmentMicrobiologyQR1-502ENmBio, Vol 9, Iss 6 (2018)
institution DOAJ
collection DOAJ
language EN
topic antitubercular
DG167
KasA
Mycobacterium tuberculosis
mycolic acid biosynthesis
drug development
Microbiology
QR1-502
spellingShingle antitubercular
DG167
KasA
Mycobacterium tuberculosis
mycolic acid biosynthesis
drug development
Microbiology
QR1-502
Pradeep Kumar
Glenn C. Capodagli
Divya Awasthi
Riju Shrestha
Karishma Maharaja
Paridhi Sukheja
Shao-Gang Li
Daigo Inoyama
Matthew Zimmerman
Hsin Pin Ho Liang
Jansy Sarathy
Marizel Mina
George Rasic
Riccardo Russo
Alexander L. Perryman
Todd Richmann
Aditi Gupta
Eric Singleton
Sheetal Verma
Seema Husain
Patricia Soteropoulos
Zhe Wang
Roxanne Morris
Gene Porter
Gautam Agnihotri
Padmini Salgame
Sean Ekins
Kyu Y. Rhee
Nancy Connell
Véronique Dartois
Matthew B. Neiditch
Joel S. Freundlich
David Alland
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
description ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interacting DG167 molecules occupying nonidentical sites in the substrate-binding channel of KasA. The binding affinities of KasA to DG167 and its analog, 5g, which binds only once in the substrate-binding channel, were determined, along with the KasA-5g X-ray crystal structure. DG167 strongly augmented the in vitro activity of isoniazid (INH), leading to synergistic lethality, and also synergized in an acute mouse model of M. tuberculosis infection. Synergistic lethality correlated with a unique transcriptional signature, including upregulation of oxidoreductases and downregulation of molecular chaperones. The lead structure-activity relationships (SAR), pharmacokinetic profile, and detailed interactions with the KasA protein that we describe may be applied to evolve a next-generation therapeutic strategy for tuberculosis (TB). IMPORTANCE Cell wall biosynthesis inhibitors have proven highly effective for treating tuberculosis (TB). We discovered and validated members of the indazole sulfonamide class of small molecules as inhibitors of Mycobacterium tuberculosis KasA—a key component for biosynthesis of the mycolic acid layer of the bacterium’s cell wall and the same pathway as that inhibited by the first-line antitubercular drug isoniazid (INH). One lead compound, DG167, demonstrated synergistic lethality in combination with INH and a transcriptional pattern consistent with bactericidality and loss of persisters. Our results also detail a novel dual-binding mechanism for this compound as well as substantial structure-activity relationships (SAR) that may help in lead optimization activities. Together, these results suggest that KasA inhibition, specifically, that shown by the DG167 series, may be developed into a potent therapy that can synergize with existing antituberculars.
format article
author Pradeep Kumar
Glenn C. Capodagli
Divya Awasthi
Riju Shrestha
Karishma Maharaja
Paridhi Sukheja
Shao-Gang Li
Daigo Inoyama
Matthew Zimmerman
Hsin Pin Ho Liang
Jansy Sarathy
Marizel Mina
George Rasic
Riccardo Russo
Alexander L. Perryman
Todd Richmann
Aditi Gupta
Eric Singleton
Sheetal Verma
Seema Husain
Patricia Soteropoulos
Zhe Wang
Roxanne Morris
Gene Porter
Gautam Agnihotri
Padmini Salgame
Sean Ekins
Kyu Y. Rhee
Nancy Connell
Véronique Dartois
Matthew B. Neiditch
Joel S. Freundlich
David Alland
author_facet Pradeep Kumar
Glenn C. Capodagli
Divya Awasthi
Riju Shrestha
Karishma Maharaja
Paridhi Sukheja
Shao-Gang Li
Daigo Inoyama
Matthew Zimmerman
Hsin Pin Ho Liang
Jansy Sarathy
Marizel Mina
George Rasic
Riccardo Russo
Alexander L. Perryman
Todd Richmann
Aditi Gupta
Eric Singleton
Sheetal Verma
Seema Husain
Patricia Soteropoulos
Zhe Wang
Roxanne Morris
Gene Porter
Gautam Agnihotri
Padmini Salgame
Sean Ekins
Kyu Y. Rhee
Nancy Connell
Véronique Dartois
Matthew B. Neiditch
Joel S. Freundlich
David Alland
author_sort Pradeep Kumar
title Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
title_short Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
title_full Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
title_fullStr Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
title_full_unstemmed Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
title_sort synergistic lethality of a binary inhibitor of <named-content content-type="genus-species">mycobacterium tuberculosis</named-content> kasa
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a3287
work_keys_str_mv AT pradeepkumar synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT glennccapodagli synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT divyaawasthi synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT rijushrestha synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT karishmamaharaja synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT paridhisukheja synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT shaogangli synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT daigoinoyama synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT matthewzimmerman synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT hsinpinholiang synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT jansysarathy synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT marizelmina synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT georgerasic synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT riccardorusso synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT alexanderlperryman synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT toddrichmann synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT aditigupta synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT ericsingleton synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT sheetalverma synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT seemahusain synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT patriciasoteropoulos synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT zhewang synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT roxannemorris synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT geneporter synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT gautamagnihotri synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT padminisalgame synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT seanekins synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT kyuyrhee synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT nancyconnell synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT veroniquedartois synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT matthewbneiditch synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT joelsfreundlich synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
AT davidalland synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa
_version_ 1718427288576458752